Apart from the increasing rate of survival, an encountered smoking cessation to reduce the recurrence rate within Non-small Cell Lung Cancer (NSCLC) was observed. High probability of complete response was seen, when the radiation therapy is initiated after the smoking session, in contrast to cases where patients continue to smoke during the treatment. A mutual accord claiming that smoking cessation prevents developing second primary tumor after diagnosing of cancer. They also found that smoking cessation after diagnoses pertains to increase the rate of survival. Al-Mamgani investigated for the preliminary evidence on the benefits of smoking cessation when cancer is diagnosed, as decreased chances of recurrence and thus, mortality.
The use of tobacco increases the chance of both the onset and cancer and interferes with the effectiveness of treatment and quality of life. There are several reasons to offer treatment of smoking since smoking continues after diagnosis can contribute to the worst result of cancer treatment, as well as the emergence of other diseases. The challenge for oncologists is to expand the treatment of cancer for health management in the long term, expanding care beyond treatment disease. The literature is scarce as the behavioral characteristics of the people in the cessation of smoking, which makes the individualization of treatment, attention, acceptance and listening skills of the physician assistant function to the success of the process.
When discussing smoking within lung cancer treatment, clarify that it is the main independent factor for overall survival in patients undergoing lung tumor. This is one of the few factors prognoses under the direct control of the patient. The information becomes active in the search for its cure. The impact of smoking on the prognosis and the quality of life of cancer patients is important and well-studied in oncology, but the physician clarifies and informs the smoker about the choice of smoking and its impact on the treatment’s effectiveness. Upon learning of the diagnosis of Cancer, the patient is more sensitive to promote behavioral diseases, which is to be addressed aimed at cessation smoking. The motivation for cessation increases, especially in patients with lung tumors and head and neck tumors. The doctors still leave study geld the great opportunity that moment to encourage patients and their families.
Literature strengthens awareness of professionals about the smoking session in cancer, which still to be studied for its importance, such as: continue smoking after diagnosis changes the effectiveness of treatment and survival and increases the risk of second primary tumor in patients. The smoking increases the hepatic metabolism; patients with tumors of the head and neck, lung had higher cessation rates smoking than patients with tumors not tobacco-related. Smoking cessation after diagnosis of lung cancer in initial stages show less improvement prognosis. Smoke during radiation therapy has lower response and survival than those who did not smoke during treatment. Patients with bladder tumors that remain hundred smoking have a worse prognosis than those who quit smoking. Smoking women undergoing radiotherapy after mastectomy increase the risk of a second primary lung tumor, especially compared to non-smokers; greater self-confidence to quit smoking is related to lower depression and stages in an initial tumor.